Compare Cassava Sciences Inc (FLNA) vs HP Inc (HPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs HP Inc — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while HP Inc trades at $23.99 (market cap $21.72B). The key difference: HP Inc is far larger — about 408.7× Cassava Sciences Inc's market cap, and HP Inc pays a 5.05% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | HPQ | |
|---|---|---|
Market Cap | $53.14M | $21.72B |
Sector | Health | Technology |
52-Week High | $4.64 | $29.35 |
52-Week Low | $1.09 | $18.20 |
Enterprise Value | -$33.43M | $28.88B |
Dividend Yield | — | 5.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
HPQ trades at $23.71, down 3.74% over 24 hours, with a bullish technical signal from moving averages and ADX indicators. Fundamentally, the stock shows value with a P/E of 8.8 and P/S of 0.39, supported by three consecutive quarterly EPS beats. Recent developments include a strategic partnership with OpenAI and a dividend yield near 5%, while cash flow trends improved to a net $460 million in 2025.
The outlook balances undervaluation and dividend appeal against PC market headwinds and negative equity. Risks include industry shipment declines and competitive pressure, but analyst consensus leans hold with a $22 price target, suggesting cautious optimism for AI-driven growth opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →
